Trellus Health (LSE:TRLS) Treasury Stock : £0.00 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Trellus Health Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. Trellus Health's treasury stock for the quarter that ended in Jun. 2024 was £0.00 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Trellus Health Treasury Stock Historical Data

The historical data trend for Trellus Health's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trellus Health Treasury Stock Chart

Trellus Health Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Treasury Stock

Trellus Health Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Treasury Stock	Get a 7-Day Free Trial			-	-	-	-	-

Trellus Health Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Trellus Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Trellus Health PLC (LSE:TRLS) » Definitions » Treasury Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

19 Stanwell Road, Avon House, Penarth, Cardiff, GBR, CF64 2EZ

Website

https://www.trellushealth.com

Trellus Health PLC is commercializing the provision of digital chronic condition management solutions for employers and health plans that utilize the scientifically validated GRITT resilience-based methodology and a proprietary HIPAA-compliant technology platform called TrellusElevate to coordinate and deliver personalized care. The company is initially focused on Inflammatory Bowel Diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis but considers its approach to have potential utility and demand across many chronic conditions.

Trellus Health Headlines

No Headlines